Germany Analysis

Pages

Industry Trend Analysis - Germany To Become Increasingly Important For Stada - SEPT 2016

Stada Arzneimittel's Central and Eastern Europe sales region saw sales in this latest quarter plummet, hampered by the ongoing economic situation in Russia and Serbia. Of more comfort to Stada has been performance in Germany, which is showing evidence of countering the country's long-standing financial squeeze on generics. The domestic market is set to become increasingly important as a bulwark...

READ FULL ARTICLE

Industry Trend Analysis - Increased Outsourcing Requirements Changing CRO Role - JULY 2016

The evolving big pharma model is catalysing deep shifts within the CRO industry, with a move towards closer collaborative relationships. Whilst CROs initially attempted to draw in big pharma partnerships though size advantages, innovation is now becoming increasingly key. CROs that offer drug discovery solutions based on data-driven platforms will be of particular interest.

READ FULL ARTICLE

Industry Trend Analysis - Generic Drug Prices Will Continue To Fall - JUNE 2016

Downward pressure on the prices of generic medicines in Germany as a result of tenders raising the level of competition, and the ultimate commoditisation of off-patent medicines, draws attention to the inherent challenges for generic drugmakers looking to profit from the government's focus on cost-containment within the healthcare sector. While the loss of value in the patented drugs segment...

READ FULL ARTICLE

Pages